AOD-9604
Mechanism
Modified fragment of growth hormone (residues 177-191) developed for fat-loss applications. Mimics the lipolytic action of full-length GH without affecting blood glucose or IGF-1. Approved as a complementary medicine in Australia (TGA).
Typical dose
300mcg subcutaneous once daily
Cycle length
12-16 weeks on, 4 weeks off
Form
Injectable (subcutaneous)
AOD-9604 protocols
Deep dives on AOD-9604
- Best Peptides for Fat Loss: What the Research Actually Shows (2026)Best peptides for fat loss ranked by real evidence: GLP-1 agonists, tirzepatide, MOTS-c, PYY3-36, and AOD-9604, graded clinical to preclinical.
- Which Peptides Are Legal Again in 2026? The Full FDA ListComplete guide to the 14 peptides returning to legal compounding status in 2026 after RFK Jr.'s FDA reclassification announcement. Every compound explained.
- What the FDA Reclassification Actually Means for Peptide UsersLearn how to evaluate peptide suppliers, read a third-party COA, spot counterfeits, and verify lab testing quality after the 2026 FDA reclassification.
- Best Peptide Protocol for Knee Cartilage Repair and Osteoarthritis Pain (2026)Evidence-based guide to peptide protocol for knee cartilage repair: BPC-157, TB-500, GHK-Cu mechanisms, intra-articular dosing, contraindications, and 2026 regulatory
- AOD-9604 Complete Guide: GH Fragment 177-191, Fat Metabolism, and TGA Approval Status (2026)AOD-9604 complete guide: mechanism, Phase IIb clinical trial results, visceral fat selectivity data, regulatory status, and 2026 research context for GH fragment 177-191.
- AOD-9604 for Fat Loss: Stubborn Fat, Body Composition, and Real-World Results (2026)AOD-9604 triggers lipolysis but failed its pivotal human trial. Here is what primary literature says about why, who benefits, and when the mechanism works.
- AOD-9604 Dosage and Cycling: Injection Timing, Fasted Cardio Stack, and Maintenance (2026)AOD-9604 dosage guide covering 250-500 mcg subcutaneous protocols, fasted cardio timing, cycling duration, and clinical trial findings from 900+ participants.
- 8 Peptides Now Legal Again in 2026: What Each One Does and Who BenefitsThe peptides legal 2026 list: BPC-157, TB-500, Semax, CJC-1295, Thymosin Alpha-1, AOD-9604, GHK-Cu and MOTS-c reviewed with evidence grades, access routes and who
Get the Pre-Protocol Checklist
Free checklist plus weekly protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.